Israel says Pfizer's COVID-19 shot is 64% effective against the infections from the delta variant

Dow Jones2021-07-06

MW Israel says Pfizer's COVID-19 shot is 64% effective against the infections from the delta variant

Israel's health ministry said Monday the effectiveness of the COVID-19 shot developed by BioNTech SE (BNTX) and Pfizer Inc. $(PFE)$ is now thought to be 64% at preventing symptomatic infections in that country. The vaccine had an efficacy rate of about 95% in clinical trials back in 2020; however, the emergence of the more transmissible delta variant in Israel has weakened the overall effectiveness of the shot, according to a statement posted on Twitter. The ministry said the vaccine remains much more effective at preventing hospitalizations and death, with an estimated effectiveness rate of 93%. Health researchers are paying close attention to vaccine performance in Israel. The country has vaccinated 57% of its residents, according to Johns Hopkins University data , and it has primarily used the BioNTech/Pfizer vaccine.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
25